SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-335163
Filing Date
2017-11-07
Accepted
2017-11-07 09:43:33
Documents
5
Period of Report
2017-11-07
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d471778d8k.htm 8-K 23367
2 EX-23.1 d471778dex231.htm EX-23.1 1776
3 EX-99.1 d471778dex991.htm EX-99.1 7637
4 GRAPHIC g471778g04b90.jpg GRAPHIC 3599
5 GRAPHIC g471778g77d44.jpg GRAPHIC 2973
  Complete submission text file 0001193125-17-335163.txt   43218
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 171181990
SIC: 2834 Pharmaceutical Preparations